^99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe by Guillermina Ferro-Flores, Blanca Ocampo-García, Pedro Cruz-Nova, Myrna Luna-Gutiérrez, Gerardo Bravo-Villegas, Erika Azorín-Vega, Nallely Jiménez-Mancilla, Emiliano Michel-Sánchez, Osvaldo García-Pérez, Nancy Lara-Almazán, Clara Santos-Cuevas

Subjects: “…PD-L1…”
Get full text

Oxymatrine Inhibits PD-L1 by Downregulating IFN-γ to Promote Ferroptosis and Enhance Anti-PD-L1 Efficacy in Liver Cancer by Nong Y, Qin H, Wei L, Wei X, Lv J, Huang X, Wu B

Subjects: Get full text

The potential of soluble programmed death-ligand 1 (sPD-L1) as a diagnosis marker for colorectal cancer by Weifang Shao, Yanhua Xu, Suzhen Lin, Junli Gao, Junshun Gao, Hong Wang

Subjects: Get full text

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma by Kina Kase, Satoru Kondo, Naohiro Wakisaka, Hirotomo Dochi, Harue Mizokami, Eiji Kobayashi, Makoto Kano, Takeshi Komori, Nobuyuki Hirai, Takayoshi Ueno, Yosuke Nakanishi, Miyako Hatano, Kazuhira Endo, Makiko Moriyama-Kita, Hisashi Sugimoto, Tomokazu Yoshizaki

Subjects: Get full text

Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma by Magdalena Zajac, Marietta Scott, Marianne Ratcliffe, Paul Scorer, Craig Barker, Hytham Al-Masri, Marlon C. Rebelatto, Jill Walker

Subjects: “…PD-L1…”
Get full text

Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma by Pei-Jhang Chiang, Ting Xu, Tai-Lung Cha, Yi-Ta Tsai, Shu-Yu Liu, Sheng-Tang Wu, En Meng, Chih-Wei Tsao, Chien-Chang Kao, Chin-Li Chen, Guang-Huan Sun, Dah-Shyong Yu, Sun-Yran Chang, Ming-Hsin Yang

Subjects: Get full text

The Potential Role of sPD-L1 as a Predictive Biomarker in EGFR-Positive Non-Small-Cell Lung Cancer by Vesna Ćeriman Krstić, Dragana Jovanović, Natalija Samardžić, Milija Gajić, Jelena Kotur Stevuljević, Aleksandra Klisic, Ivan Soldatović, Damir Radončić, Marina Roksandić Milenković, Biljana Šeha, Nikola Čolić, Katarina Lukić, Milan Savić

Subjects: Get full text

Exosomal PD-L1 in cancer and other fields: recent advances and perspectives by Man-Man Lu, Yu Yang

Subjects: Get full text

Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease by Ayaka Hayashi, Ayaka Hayashi, Hiroto Ishihara, Mayuko Kawabe, Kazuhiko Kato, Kazuhiko Kato, Akio Nakashima, Akio Nakashima, Izumi Yamamoto, Teppei Sakano, Teppei Sakano, Hiroe Kobashi, Makoto Morita, Makoto Morita, Takashi Yokoo, Mitsuyoshi Urashima

Subjects: Get full text

Local immune checkpoint blockade therapy by an adenovirus encoding a novel PD-L1 inhibitory peptide inhibits the growth of colon carcinoma in immunocompetent mice by Susumu Ishiguro, Deepa Upreti, Molly Bassette, E.R. Azhagiya Singam, Ravindra Thakkar, Mayme Loyd, Makoto Inui, Jeffrey Comer, Masaaki Tamura

Subjects: Get full text

Advances in the Influence of EGFR Mutation on the PD-L1 Expression in Non-small Cell Lung Cancer by Xiaoyu ZHI, Weiwei LI, Shaowei WANG, Jinliang WANG

Subjects: Get full text

PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation by Jesus Pacheco-Torres, Marie-France Penet, Marie-France Penet, Balaji Krishnamachary, Yelena Mironchik, Zhihang Chen, Zaver M. Bhujwalla, Zaver M. Bhujwalla, Zaver M. Bhujwalla

Subjects: Get full text

Avelumab for the treatment of patients with Merkel cell carcinoma by K. V. Orlova, N. N. Petenko, V. V. Nazarova, L. V. Demidov

Subjects: Get full text

Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report by Ali McBride, Andrew J. Garcia, Lauren J. Sanders, Kelly Yiu, Lee D. Cranmer, Phillip H. Kuo, Matthew Kay, Andrew S. Kraft

Subjects: Get full text

The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells by Zhuo Chen, Meng-Wei Yao, Xiang Ao, Qing-Jia Gong, Yi Yang, Jin-Xia Liu, Qi-Zhou Lian, Xiang Xu, Ling-Jing Zuo

Subjects: “…PD-L1…”
Get full text

Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression by Gabriele Gaggero, Michela Campora, Davide Taietti, Giannamaria Cerruti, Enrico Lo Bue, Monica Truffelli, Marco Ceraudo, Pietro Fiaschi

Subjects: Get full text

Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1 by Karolina Okła, Alicja Rajtak, Arkadiusz Czerwonka, Marcin Bobiński, Anna Wawruszak, Rafał Tarkowski, Wiesława Bednarek, Justyna Szumiło, Jan Kotarski

Subjects: Get full text

Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme—a retrospective cohort study by Aetsam Bin Masood, Sajida Batool, Sajid Nazir Bhatti, Asad Ali, Marian Valko, Klaudia Jomova, Kamil Kuca, Kamil Kuca

Subjects: Get full text

ExoPD-L1: an assistant for tumor progression and potential diagnostic marker by Rong Hu, Rong Hu, Md Shoykot Jahan, Md Shoykot Jahan, Lijun Tang, Lijun Tang

Subjects: “…ExoPD-L1…”
Get full text

Prostate cancer cells synergistically defend against CD8+ T cells by secreting exosomal PD‐L1 by Dameng Li, Xueying Zhou, Wenxian Xu, Yuxin Chen, Chenglong Mu, Xinchun Zhao, Tao Yang, Gang Wang, Liang Wei, Bo Ma

Subjects: Get full text